1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Esco Lifesciences Acquires Evidence

M&A Deal Summary

Esco Lifesciences Acquires Evidence

On July 6, 2022, Esco Lifesciences acquired software company Evidence

Acquisition Highlights
  • This is Esco Lifesciences’ 1st transaction in the Software sector.
  • This is Esco Lifesciences’ 1st transaction in the United States.

M&A Deal Summary
Date 2022-07-06
Target Evidence
Sector Software
Buyer(s) Esco Lifesciences
Deal Type Add-on Acquisition

Target

Evidence

United States
Evidence is a software company offering In Vitro Fertilization (IVF) management technologies and quality management systems ("Evidence witness system"). Evidence witness system is a witnessing, labelling, workflow scheduling and traceability system, specifically built for IVF clinics to prevent treatment errors.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Esco Lifesciences

Singapore, Singapore
Category Company
Founded 1978
Sector Life Science
Employees1,500
DESCRIPTION

Esco Lifesciences is a life sciences company, expanded globally, with business presence in over 130 countries across the US, Europe, the UK, China, Singapore, etc. Esco Lifesciences was founded in 1978 and is based in Singapore.

DEAL STATS #
Overall 1 of 1
Sector: Software M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: United States M&A 1 of 1
Year: 2022 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal